UK consumers scaled back on their food and alcohol purchases during the festive season, with industry experts attributing this trend to the increasing use of weight loss injections. Despite a 2.5% growth in total grocery sales amounting to £19.6 billion for the four weeks leading up to December 27, sales volume saw a slight decline of 0.2%, as reported by market research firm NielsenIQ.
Analysts in the retail sector suggest that the surge in individuals opting for GLP-1 injections, which simulate a crucial hormone to induce a quicker feeling of fullness, is linked to the reduced consumption levels. The National Health Service (NHS) recommends Mounjaro and Wegovy injections for weight loss and Ozempic specifically for diabetes. Recent data from University College London estimates that approximately 1.6 million adults in the UK have utilized these injections in the past year.
Retail expert Jonathan De Mello noted the observable impact of the “Ozempic effect” on grocery trends, with a notable rise in GLP-1 usage leading to a year-on-year decrease in the volume of groceries purchased. This shift has particularly affected high-calorie categories such as snacks and alcohol. As this pattern gains traction, retailers are urged to adjust their product offerings to align with the evolving consumer preference for quality over quantity.
Clive Black, a consumer analyst at Shore Capital, highlighted the dip in grocery sales volume over the Christmas period as a clear indication of the influence of GLP drugs on dietary habits. Major supermarket chains have responded to this trend by introducing smaller meal options. For instance, Co-op launched a range of “mini meals” catering to those with smaller appetites, while Marks & Spencer unveiled a new “nutrient dense” product line, and Iceland expanded its frozen meal selection with 38 additional options.
The impact of weight loss injections on consumer behavior has also been acknowledged by industry leaders. Greggs’ CEO mentioned the discernible effect of these medications on their business performance, emphasizing the growing demand for smaller portions and healthier choices among customers. Tesco’s chief executive and Sainsbury’s CEO both emphasized the importance of closely monitoring consumer behavior in light of the rising popularity of weight loss treatments.
The evolving landscape of consumer preferences, influenced by factors like weight loss injections, is prompting retailers to adapt and innovate their offerings to meet the changing demands of health-conscious shoppers.